MSD’s immunotherapy Keytruda gets green signal from US for skin cancer
MSD’s immunotherapy Keytruda has been allowed an extended mark to incorporate the therapy of specific patients with locally advanced cutaneous
Read moreMSD’s immunotherapy Keytruda has been allowed an extended mark to incorporate the therapy of specific patients with locally advanced cutaneous
Read more